Features | Partner Sites | Information | LinkXpress
Sign In
AMPRONIX
TERARECON, INC.
SCHILLER AG

Near Infrared-2 Imaging Technology Developed for Visualizing Blood Flow

By Medimaging International staff writers
Posted on 26 Dec 2012
Image: These images of a mouse's blood vessels show the difference in resolution between traditional near-infrared fluorescence imaging (top) and Stanford's new NIR-2 technique (bottom) (Photo courtesy of Stanford University).
Image: These images of a mouse's blood vessels show the difference in resolution between traditional near-infrared fluorescence imaging (top) and Stanford's new NIR-2 technique (bottom) (Photo courtesy of Stanford University).
Investigators have developed a fluorescence imaging technique that provides a view of the pulsing blood vessels of living animals with never-before-seen clarity. Compared with traditional imaging technologies, the sharpness enhancement is similar to cleaning fog off eyeglasses.

The technique, called near infrared-2 imaging (NIR-2), involves first injecting water-soluble carbon nanotubes into the live subject’s bloodstream. The researchers then shine a laser (its light is in the near-infrared range, a wavelength of about 0.8 micrometers) over the subject—in this instance, a mouse. The light causes the specially engineered nanotubes to fluoresce at a longer wavelength of 1-1.4 micrometers, which is then detected to determine the blood vessels’ structure.

That the nanotubes fluoresce at considerably longer wavelengths than conventional imaging techniques is vital in achieving the amazingly sharp images of the tiny blood vessels: longer wavelength light scatters less, and thereby generates clearer images of the vessels. Another advantage of detecting such long wavelength light is that the detector registers less background noise since the body does not produce autofluorescence in this wavelength range.

In addition to providing fine details, the technique, developed by Stanford University (Stanford, CA, USA) scientists Hongjie Dai, PhD, professor of chemistry; John Cooke, MD, PhD, professor of cardiovascular medicine; and Ngan Huang, PhD, acting assistant professor of cardiothoracic surgery—has a fast image acquisition rate, allowing researchers to measure blood flow in near real time.

The research was published online November 18, 2012, in the journal Nature Medicine. The ability to obtain both blood flow data and blood vessel clarity was not earlier possible, and will be especially useful in studying animal models of arterial disease, such as how blood flow is affected by the arterial blockages and constrictions that cause, among other things, heart attacks and stroke. “For medical research, it’s a very nice tool for looking at features in small animals,” Prof. Dai said. “It will help us better understand some vasculature diseases and how they respond to therapy, and how we might devise better treatments.”

Because NIR-2 can only penetrate 1 cm, at most, into the body, it will not replace other imaging techniques for humans, but it will be a powerful method for studying animal models by replacing or complementing computed tomography (CT), X-ray, magnetic resonance imaging (MRI), and laser Doppler techniques.

The next phase of the research, and one that will make the technology more easily accepted for use in humans, is to study alternative fluorescent molecules, according to Prof. Dai. “We’d like to find something smaller than the carbon nanotubes but that emit light at the same long wavelength, so that they can be easily excreted from the body and we can eliminate any toxicity concerns.”

Related Links:

Stanford University



RADCAL
SuperSonic Imagine
RTI ELECTRONICS AB

Channels

MRI

view channel
Image: The quantitative character of the novel 3D technique on MR scans from a patient with primary liver cancer is demonstrated. Images A and B show the scan of the patient before being treated with chemoembolization. The new 3D technique helped quantify the volume and distribution of viable tumor tissue (shown in red and yellow colors). Images C and D demonstrate MR scans acquired after the treatment. The new 3D method helped the radiologists to quantify the vast central destruction of the tumor after the treatment (the dead tumor is represented by the blue color) (Photo courtesy of Johns Hopkins Medicine).

3D MRI Offers Improved Prediction of Survival After Chemotherapy for Liver Tumors

Researchers are using specialized three-dimensional (3D) magnetic resonance imaging (MRI) scanning technology to accurately measure living and dying liver tumor tissue in order to quickly show whether... Read more

Ultrasound

view channel
Image: Siemens Healthcare has launched the HELX Evolution, the newest iteration of its Acuson S range of ultrasound imaging systems (Photo courtesy of Siemens Healthcare).

Ultrasound Imaging System Enhancements Include High Definition Transducers, Sophisticated Elastography, and Tissue Strain Analysis

New features designed for a range of ultrasound systems include enhanced image quality with a large 21.5-inch liquid crystal diode (LCD) monitor, high definition (HD) transducers, optimized contrast agent... Read more

Nuclear medicine

view channel
Image: Sagittal section of brain PET image at four hours after 64CuCl2 injection with disulfiram or D-penicillamine in MD model mice (Photo courtesy of the RIKEN Center for Life Science Technologies).

PET Imaging Used to Assess Effectiveness of Menkes Disease Treatments

Japanese scientists are using positron emission tomography (PET) imaging to visualize the distribution of copper in the body using lab mice. Copper distribution is deregulated in a genetic disorder called... Read more

Imaging IT

view channel

Software Designed for the Assessment of Orthopedic Implant Fixation and Bone Segment Motion

Model-based roentgen stereophotogrammetric analysis (MBRSA) software has been developed for evaluation of orthopedic implant fixation and bone segment motion. The software is the first to measure the in vivo three-dimensional (3D) position and/or relative motion of metal implants, markers beads, and/or bone segments in... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.